ClinicalTrials.gov
ClinicalTrials.gov Menu

PTX-200 and Carboplatin in Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01690468
Recruitment Status : Recruiting
First Posted : September 21, 2012
Last Update Posted : January 12, 2018
Sponsor:
Information provided by (Responsible Party):
Prescient Therapeutics, Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018